Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.525 USD | +19.10% | +22.34% | -19.40% |
02:58pm | Investor Sentiment Muted After Rate Cut Optimism, Stifling US Equity Futures Pre-Bell | MT |
02:01pm | Top Premarket Gainers | MT |
Evolution of the average Target Price on Esperion Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Esperion Therapeutics, Inc.
Needham & Co. | |
Northland Securities | |
TD Cowen | |
BofA Securities | |
Morgan Stanley | |
Credit Suisse | |
JPMorgan Chase | |
HC Wainwright | |
Goldman Sachs | |
JMP Securities | |
Stifel Nicolaus | |
BTIG | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- ESPR Stock
- Consensus Esperion Therapeutics, Inc.